Cargando…
AB053. Labeling of prostate tumor-specific replication-selective oncolytic adenoviruses with radioactive 125I: inhibitory effects on prostate cancer cell
BACKGROUND: The authors established a 125I-labeled replication-selective oncolytic adenovirus and human telomerase reverse transcriptase/prostate-specific antigen (125I-RSOAds-hTERT/PSA) oncolytic adenovirus marker and investigated the effects of different labeling conditions. This study also explor...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565601/ http://dx.doi.org/10.21037/tau.2017.s053 |